Join Hafta-Ichi to Research the article “Coronavirus live news: Pfizer and AstraZeneca jab offer protection against India Covid variant, PHE finds”
Latest updates: Pfizer vaccine 88% effective against symptomatic disease from the India variant after second dose, AstraZeneca jab 60% effective
- Pfizer and AstraZeneca ‘highly effective’ against India Covid variant
- Ministers ‘failed to act on Bedford Covid variant surge for two weeks’
- CDC studying reports of heart inflammation in young vaccine recipients
- No 10 ‘tried to block’ data on spread of new variant in English schools
- See all our coronavirus coverage
Some teenagers and young adults who received Covid-19 vaccines have experienced heart inflammation, a US Centers for Disease Control and Prevention advisory group has said, recommending further study of the rare condition.
In a statement dated 17 May, the CDC’s advisory committee on immunisation practices said it had looked into reports that a few young vaccine recipients, predominantly male adolescents and young adults, developed myocarditis, an inflammation of the heart muscle.
The condition often goes away without complications and can be caused by a variety of viruses, the CDC group said.
Related: CDC studying reports of heart inflammation in young Covid vaccine recipients
Good morning, good afternoon and good evening to everyone joining our live coverage today of coronavirus and political news from around the world, centred on events in the UK.
One of the top stories this morning is news of a Public Health England student that has found both the Pfizer and AstraZeneca jabs are highly effective at protecting people from the strain of the Covid-19 virus first found in India.
Related: Pfizer and AstraZeneca ‘highly effective’ against India Covid variant
Source: The Guardian
Keyword: Coronavirus live news: Pfizer and AstraZeneca jab offer protection against India Covid variant, PHE finds